Dr Lena Unterrainer presented [Ga-68]EMP-100 as one of the "dark horses of theranostics" and showed the data of [Ga-68]EMP-100 in NSCLC.
Filter news by category :
Results published by Investigator on non-invasive assessment of c-MET expression in non-small cell lung cancer
A case of a 56-year-old female former smoker with stage IV EGFR mutation-positive NSCLC (lymphogenic, pulmonary, hepatic, and cerebral metastases is presented. Stage: cT3, cN3, cM1b) and concomitant MET exon 14 skipping mutation. After multiple pretreatments including radiochemotherapy and...
Results published by Investigator on first-in-human biodistribution and first PET imaging results of [Ga-68]EMP-100 in metastatic renal cell carcinoma
This first in‑human biodistribution and imaging study for 68Ga‑EMP‑100 in metastatic renal cell carcinoma independently carried out by LMU Munich, Germany, evaluated uptake characteristics in metastases and primary RCC. Conclusion: Visualization of c-MET expression with 68Ga-EMP-100 PET imaging...